Skip directly to content


July 2012

HIV, Hepatitis C Virus (HCV), and Tuberculosis (TB) Drugs, Diagnostics, Vaccines, and Preventive Technologies in Development

By Polly Clayden, Simon Collins, Colleen Daniels, Nathan Geffen, Mark Harrington, Richard Jefferys, Coco Jervis, Karyn Kaplan, Erica Lessem, and Tracy Swan

Edited by Andrea Benzacar

Introduction and Executive Summary

The Antiretroviral Pipeline (Updated Sep 2012)

The Pediatric Antiretroviral Pipeline (Updated Aug 2012)

Retrofitting for Purpose: Treatment Optimization (Updated Aug 2012)

Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies (Updated Feb 2013)

Hepatitis C Drug Development Goes from Pony Ride to Rocket Launch 

Hepatitis C Drug Development Update from AASLD (Dec 2012)

Hepatitis C Treatment Access: Spotlight on Thailand/Asia

The Tuberculosis Diagnostics Pipeline

The Tuberculosis Treatment Pipeline (Updated Feb 2013)

The Tuberculosis Vaccine Pipeline (Updated Feb 2013)